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Background: Revascularization surgery remains the chosen treatment for most lesions of the unprotected left main coronary artery. However, there 
are multiple series of patients treated percutaneously with outcomes comparable to surgery. 
Material and Methods: A multicenter, prospective register performed at 30 hospitals in Spain. From Nov-2007 to Nov-2008 all consecutive 
patients with a significant involvement of the LM, with indication of revascularization treatment with PCI or surgery, were included consecutively in a 
database via web and were followed during their hospital stay, at 6 and 12 months. Primary endpoint were major adverse cardiac events (death, AMI 
and new revascularization) at 6 and 12 months after percutaneous treatment of the LM and in patients undergoing surgery. This paper analyses only 
the hospital outcomes of patients undergoing PCI.
Results: 1493 patients were included, 796 treated with PCI (53.3%). The mean age was 69.4±10.5 years, and the number of patients aged ≥75 
years was significantly higher in the PCI group (45.4% vs 28.8%, p< 0.001). Regard to risk factors, only dyslipidemia was significantly more common 
in the CABG group (63.5 vs. 58.6%, p<0.01). The indication for revascularization was NSTEACS in 49.2%, STEAMI in 8.9%, and cardiogenic shock in 
4%.The lesions were located in the distal left main in 54.5% with lesions in other vessels in 61.9% (84.6% the AD, 26.9 the CX, and 12.4% the RC). 
The left main coronary artery was treated with a single stent in 87% of the cases, and when two stents were used, the techniques used were: crush 
39.3%, T stent 30.8%, kissing stent 22.4%, and coulotte 4.7%. DES was used in 79.9%, obtaining complete revascularization in 46.9%. The success 
of the procedure was 96.4%. During the hospital stay, 4.1% had Q-wave AMI, and overall mortality of any type was 5.4%. The MACE rate during 
hospital stay was 9.9%. Excluding patients with AMI and shock, mortality was 2.3%, Q-wave AMI rate was 3.1% and MACE 5.8%.
Conclusions: Percutaneous revascularization is an alternative to surgery in LM disease. High-risk patients are more likely to be treated with PCI, 
with a higher percentage of women, subjects aged over 75 years, those with AMI, and cardiogenic shock.
